bf/NASDAQ:BMRN_icon.png

NASDAQ:BMRN

BioMarin Pharmaceutical Inc.

  • Stock

USD

Last Close

83.80

03/05 20:00

Market Cap

17.12B

Beta: 0.38

Volume Today

1.60M

Avg: 1.37M

PE Ratio

112.42

PFCF: 528.69

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-176.35M
-
-133.97M
24.03%
-171.80M
28.24%
-630.21M
266.83%
-117.04M
81.43%
-77.21M
34.03%
-23.85M
69.11%
859.10M
3,702.40%
-64.08M
107.46%
141.56M
320.91%
167.65M
18.43%
depreciation and amortization
47.26M
-
56.74M
20.06%
47.19M
16.84%
96.91M
105.38%
87.86M
9.34%
95.67M
8.89%
105.30M
10.06%
105.17M
0.12%
108.04M
2.73%
101.97M
5.62%
104.39M
2.37%
deferred income tax
-9.16M
-
-25.48M
178.32%
-76.83M
201.48%
-228.05M
196.84%
44.46M
119.50%
-68.38M
253.78%
-82.76M
21.03%
-888.91M
974.08%
-15.61M
98.24%
-52.09M
233.72%
-44.98M
13.64%
stock based compensation
66.18M
-
88.23M
33.32%
111.53M
26.40%
134.64M
20.73%
140.26M
4.18%
148.82M
6.10%
159.87M
7.42%
189.71M
18.67%
197.26M
3.98%
196.31M
0.48%
207.10B
105,396.97%
change in working capital
-23.08M
-
-30.34M
31.43%
46.33M
252.71%
-160.28M
445.93%
-93.96M
41.37%
-49.42M
47.40%
-101.09M
104.56%
-224.42M
121.99%
66.03M
129.42%
-96.38M
245.96%
-336.54M
249.17%
accounts receivables
-8.76M
-
-26.65M
204.36%
-16.37M
38.59%
-51.48M
214.55%
-25.26M
50.94%
-54.27M
114.90%
-37.85M
30.26%
-59.03M
55.96%
65.57M
211.08%
-82.03M
225.10%
-190.44M
132.14%
inventory
-33.91M
-
-36.85M
8.66%
-50.99M
38.38%
-64.51M
26.52%
-96.89M
50.19%
-23.75M
75.49%
-107.55M
352.92%
-61.15M
43.14%
-35.06M
42.67%
-68.26M
94.71%
-157.06M
130.07%
accounts payables
8.35M
-
36.50M
337.27%
116.10M
218.09%
-33.89M
129.19%
24.83M
173.27%
20.62M
16.95%
50.08M
142.85%
-68.71M
237.20%
15.69B
22,932.65%
59.02M
99.62%
68.85M
16.66%
other working capital
11.23M
-
-3.34M
129.75%
-2.41M
27.89%
-10.39M
331.20%
3.35M
132.27%
7.98M
137.97%
-5.77M
172.28%
-35.52M
515.88%
-15.65B
43,971.96%
-5.10M
99.97%
-57.90M
1,034.38%
other non cash items
35.51M
-
-28.72M
180.88%
-178.11M
520.06%
559.15M
413.94%
-70.34M
112.58%
-29.27M
58.38%
-9.20M
68.56%
44.71M
585.78%
12.89M
71.17%
-115.47M
995.92%
-206.83B
179,026.54%
net cash provided by operating activities
-59.63M
-
-73.54M
23.32%
-221.69M
201.46%
-227.84M
2.77%
-8.76M
96.16%
20.21M
330.76%
48.26M
138.83%
85.36M
76.88%
304.54M
256.75%
175.90M
42.24%
159.26M
9.46%
investments in property plant and equipment
-65.12M
-
-118.83M
82.47%
-227.65M
91.57%
-148.38M
34.82%
-199.22M
34.26%
-144.62M
27.41%
-163.41M
12.99%
-137.52M
15.84%
-119.22M
13.30%
-131.54M
10.33%
-107.61M
18.19%
acquisitions net
-10.76M
-
-1.10M
89.78%
-910.15M
82,640.73%
-2.79M
99.69%
125M
4,581.89%
50M
60%
6.62M
86.76%
-23.21M
450.56%
-23.65M
1.90%
10.92B
-
purchases of investments
-395.04M
-
-559.32M
41.59%
-876.51M
56.71%
-699.75M
20.17%
-655.45M
6.33%
-634.75M
3.16%
-632.02M
0.43%
-538.37M
14.82%
-937.14M
74.07%
-611.81M
34.72%
-868.50M
41.96%
sales maturities of investments
288.64M
-
808.31M
180.04%
424.71M
47.46%
367.57M
13.45%
425.96M
15.89%
993.73M
133.29%
740.21M
25.51%
555.83M
24.91%
691.05M
24.33%
620.00M
10.28%
864.86M
39.50%
other investing activites
-116.50M
-
65.50M
156.22%
410M
525.95%
-698K
100.17%
-1.75M
151.15%
-10K
99.43%
17.57M
175,820%
89.64M
410.15%
22.65M
74.73%
103.33M
356.12%
-10.92B
10,668.59%
net cash used for investing activites
-298.78M
-
194.56M
165.12%
-1.18B
706.31%
-484.05M
58.97%
-305.46M
36.89%
264.35M
186.54%
-31.03M
111.74%
-53.62M
72.83%
-366.31M
583.15%
-20.03M
94.53%
-111.24M
455.41%
debt repayment
-13.57M
-
-674K
95.03%
-163K
75.82%
-374.95M
-
-5.09M
98.64%
-381.91M
7,407.55%
-3.04M
99.20%
-2.60M
14.28%
-2.29M
12.25%
common stock issued
117.46M
-
888.26M
656.20%
712.94M
19.74%
31.61M
-
71.91M
127.49%
49.19M
31.59%
69.33M
40.94%
69.35M
0.03%
common stock repurchased
-42.68M
-
-50M
17.15%
-45.80M
8.39%
-54.28M
18.51%
dividends paid
-11.07M
-
-71.91M
549.68%
-3.39M
95.29%
-15.05M
344.08%
other financing activites
760.24M
-
68.90M
90.94%
39.82M
42.21%
14.17M
64.41%
507.14M
3,479.00%
-13.05M
102.57%
-47.45M
263.48%
613.03M
1,391.97%
2.99M
99.51%
-16.05M
636.44%
-85.79M
434.71%
net cash used provided by financing activities
746.67M
-
185.69M
75.13%
927.91M
399.71%
727.11M
21.64%
507.14M
30.25%
-388.01M
176.51%
-74.67M
80.75%
181.12M
342.54%
-48K
100.03%
-18.65M
38,754.17%
-18.73M
0.41%
effect of forex changes on cash
-5.07M
-
-3.93M
22.44%
-3.23M
17.87%
-598K
81.49%
902K
250.84%
-1.15M
227.49%
-57K
95.04%
32K
156.14%
1.31B
4,087,400%
net change in cash
388.25M
-
306.70M
21.00%
-478.45M
256.00%
11.29M
102.36%
189.70M
1,580.23%
-104.05M
154.85%
-56.54M
45.66%
211.71M
474.47%
-61.88M
129.23%
137.25M
321.80%
30.60M
77.71%
cash at beginning of period
180.53M
-
568.78M
215.07%
875.49M
53.92%
397.04M
54.65%
408.33M
2.84%
598.03M
46.46%
493.98M
17.40%
437.45M
11.44%
649.16M
48.40%
587.28M
9.53%
724.53M
23.37%
cash at end of period
568.78M
-
875.49M
53.92%
397.04M
54.65%
408.33M
2.84%
598.03M
46.46%
493.98M
17.40%
437.45M
11.44%
649.16M
48.40%
587.28M
9.53%
724.53M
23.37%
755.13M
4.22%
operating cash flow
-59.63M
-
-73.54M
23.32%
-221.69M
201.46%
-227.84M
2.77%
-8.76M
96.16%
20.21M
330.76%
48.26M
138.83%
85.36M
76.88%
304.54M
256.75%
175.90M
42.24%
159.26M
9.46%
capital expenditure
-65.12M
-
-118.83M
82.47%
-227.65M
91.57%
-148.38M
34.82%
-199.22M
34.26%
-144.62M
27.41%
-163.41M
12.99%
-137.52M
15.84%
-119.22M
13.30%
-131.54M
10.33%
-107.61M
18.19%
free cash flow
-124.76M
-
-192.37M
54.20%
-449.34M
133.58%
-376.22M
16.27%
-207.98M
44.72%
-124.41M
40.18%
-115.14M
7.45%
-52.15M
54.71%
185.31M
455.32%
44.36M
76.06%
51.65M
16.42%

All numbers in USD (except ratios and percentages)